针对性蛋白质降解:当前的分子目标,定位和策略
Dimanthi Pliatsika1, Cindy Blatter1, Rainer Riedl1
1Institute of Chemistry and Biotechnology, Competence Center for Drug Discovery, Zurich University of Applied Sciences, CH-8820 Wädenswil, Switzerland.
Drug discovery today
|September 14, 2024
概括
向蛋白降解 (TPD) 通过消除特定蛋白质来改变药物发现. 这篇评论探讨了TPD的情况.
科学领域:
- 生物化学和分子生物学
- 药理学和药物发现
- 细胞生物学 细胞生物学
背景情况:
- 向蛋白质降解 (TPD) 已成为一种强大的治疗方式.
- 最初专注于细胞内点,TPD的范围已经显著扩大.
- 这一领域在过去二十年里不断发展,扩展到癌症治疗之外.
研究的目的:
- 审查针对性蛋白质降解的不断扩大的景观.
- 突出超越传统应用的新型蛋白质点.
- 讨论针对具有挑战性的蛋白质位置的策略,例如细胞外基质和膜.
主要方法:
- 关于TPD近期进展的综合文献综述.
- 对各种蛋白质标应用的TPD策略的分析.
- 检查TPD在各种疾病背景中的应用.
主要成果:
- TPD越来越多地应用于更广泛的蛋白质和疾病.
- 准细胞外矩阵和膜蛋白带来了新的机遇和挑战.
- 针对难以获得的毒品目标,正在开发创新的TPD策略.
结论:
- 通过向各种蛋白质,TPD具有治疗各种疾病的巨大潜力.
- 克服针对细胞外和膜蛋白的挑战对于未来的TPD发展至关重要.
- 本综述提供了对药物发现TPD中不断发展的战略和未来方向的见解.
相关概念视频
Regulated Protein Degradation
2.5K
2.5K
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Directing Proteins to the Rough Endoplasmic Reticulum
7.2K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
7.2K


